Hemant Bhargav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hemant Bhargav has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
Nishitha Jasti
Department of Integrative Medicine Bengaluru Karnataka 560029 National Institute of Mental Health And Neuro Sciences
10 shared publicationsShivarama Varambally
Department of Psychiatry Bengaluru Karnataka 560029 National Institute of Mental Health and Neuro Sciences
10 shared publications- Bharath Holla
Intergrative Medicine Bengaluru Karnataka 560029 National Institute of Mental Health and Neurosciences (NIMHANS))
9 shared publications Jayant Mahadevan
Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS) , Bengaluru, Karnataka
8 shared publicationsBharath Holla
Department of Integrative Medicine, National Institute of Mental Health and Neurosciences (NIMHANS) , Bengaluru, Karnataka
6 shared publicationsAmit Singh
Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS) , Bengaluru, Karnataka
5 shared publications
Latest Publications
- 2 November 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
Efficacy of a Validated Yoga-Breath Linked Intervention (Y-BLISS) for smoking cessation: A Randomized Controlled Trial
Introduction: Tobacco use disorder remains a global health concern, and safe complementary interventions are needed. We evaluated a validated Yoga-Breath Linked Intervention to Stop Smoking (Y-BLISS). Methods: In this randomized controlled trial, 139 smokers meeting DSM-5 criteria for tobacco use disorder with moderate to severe nicotine dependence (Fagerström Test for Nicotine Dependence, FTND ≥4) were randomized to Y-BLISS (n = 70) or desktop exercise control (n = 69). Y-BLISS comprised a 12-minute yoga-breath protocol with single-session yoga philosophy-based psychotherapy, delivered online under live supervision 5 days/week for 8 weeks. Controls received attention-matched desktop exercise with health education. The primary outcome was cigarettes per day (CPD). Secondary outcomes included 7-day point-prevalence abstinence, FTND, Tobacco Craving Questionnaire Short Form (TCQ-SF), peak expiratory flow rate (PEFR), and exhaled carbon monoxide (eCO). Assessments occurred at baseline, 4 and 8 weeks; analysis was intention-to-treat with linear mixed-effects models. Results: Baseline characteristics were broadly comparable, with slightly higher dependence and craving in Y-BLISS (mean age 38.7 ± 8.6 years; 95% male; FTND 5.2 ± 1.2). At 8 weeks, Group × Time effects (β, 95% CI) favored Y-BLISS for CPD, FTND, TCQ-SF and PEFR, all p < 0.001, and eCO (p = .04). Seven-day point-prevalence abstinence was 25.7% versus 11.6% (odds ratio 2.64, 1.06 to 6.57; p = 0.037). Differences were already present at 4 weeks for CPD, FTND, TCQ-SF and PEFR. Conclusions: These findings support Y-BLISS as a promising adjunct to standard cessation care and justify longer-term, multicenter effectiveness and implementation trials.
- 2 November 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
Efficacy of a Validated Yoga-Breath Linked Intervention (Y-BLISS) for smoking cessation: A Randomized Controlled Trial
Introduction: Tobacco use disorder remains a global health concern, and safe complementary interventions are needed. We evaluated a validated Yoga-Breath Linked Intervention to Stop Smoking (Y-BLISS). Methods: In this randomized controlled trial, 139 smokers meeting DSM-5 criteria for tobacco use disorder with moderate to severe nicotine dependence (Fagerström Test for Nicotine Dependence, FTND ≥4) were randomized to Y-BLISS (n = 70) or desktop exercise control (n = 69). Y-BLISS comprised a 12-minute yoga-breath protocol with single-session yoga philosophy-based psychotherapy, delivered online under live supervision 5 days/week for 8 weeks. Controls received attention-matched desktop exercise with health education. The primary outcome was cigarettes per day (CPD). Secondary outcomes included 7-day point-prevalence abstinence, FTND, Tobacco Craving Questionnaire Short Form (TCQ-SF), peak expiratory flow rate (PEFR), and exhaled carbon monoxide (eCO). Assessments occurred at baseline, 4 and 8 weeks; analysis was intention-to-treat with linear mixed-effects models. Results: Baseline characteristics were broadly comparable, with slightly higher dependence and craving in Y-BLISS (mean age 38.7 ± 8.6 years; 95% male; FTND 5.2 ± 1.2). At 8 weeks, Group × Time effects (β, 95% CI) favored Y-BLISS for CPD, FTND, TCQ-SF and PEFR, all p < 0.001, and eCO (p = .04). Seven-day point-prevalence abstinence was 25.7% versus 11.6% (odds ratio 2.64, 1.06 to 6.57; p = 0.037). Differences were already present at 4 weeks for CPD, FTND, TCQ-SF and PEFR. Conclusions: These findings support Y-BLISS as a promising adjunct to standard cessation care and justify longer-term, multicenter effectiveness and implementation trials.
- Open Access
- 26 October 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 918
Tele-Adaptation and Feasibility of a Brief Yoga Therapy Module for Generalized Anxiety Disorder: A Pilot Study
Background Generalized Anxiety Disorder (GAD) is highly prevalent, but access barriers limit treatment uptake. We systematically tele-adapted a validated 90-minute yoga therapy module into a brief 30-minute format and evaluated its acceptability, feasibility, and preliminary clinical effects. Methods Using expert content validation (n = 10), we developed a 30-minute tele-yoga module comprising Sukshma Vyayama, Vibhagiya Pranayama (6:4:8:4 ratio), Chandra Anuloma Viloma (4:8 ratio), Nadishodhana Pranayama, Bhramari Pranayama, and Yoga Nidra. Twenty adults (18 to 55 years) diagnosed with GAD (GAD-7 score of 5 or higher), with or without comorbid neurotic disorder, on stable pharmacotherapy or drug-naive, received one in-person orientation followed by thrice-weekly live tele-yoga sessions and weekly yoga philosophy discussions over 8 weeks. Primary outcomes included feasibility metrics: Acceptability of Intervention Measure (AIM), Feasibility of Intervention Measure (FIM), Client Satisfaction Questionnaire (CSQ), attendance, dropout rate, and Yoga Performance Assessment (YPA). Secondary outcomes were GAD-7 and Pittsburgh Sleep Quality Index (PSQI) at baseline, 4 weeks, and 8 weeks. The Friedman test was used for repeated-measures analysis on completers (n = 17). Results Seventeen of 20 participants (85%) completed the intervention with over 80% attendance. Three withdrew for non-intervention reasons. All feasibility criteria were met: AIM 4.52 +/− 0.21, FIM 4.45 +/− 0.18, CSQ 30.05 +/− 1.14, YPA 30.11 +/− 1.36. GAD-7 scores decreased significantly from a median of 13.0 (IQR 11.0 to 15.0) at baseline to 7.0 (IQR 6.0 to 8.0) at 8 weeks (chi-square = 33.52, p < 0.001). PSQI improved from 12.0 (IQR 11.0 to 15.0) to 7.0 (IQR 4.0 to 7.0) (chi-square = 31.39, p < 0.001). No adverse events occurred. Conclusions This brief tele-adapted yoga module is feasible, acceptable, and shows promising preliminary effects on anxiety and sleep quality in GAD. Randomized controlled trials are warranted.
- 26 October 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 918
Open AccessTele-Adaptation and Feasibility of a Brief Yoga Therapy Module for Generalized Anxiety Disorder: A Pilot Study
Background Generalized Anxiety Disorder (GAD) is highly prevalent, but access barriers limit treatment uptake. We systematically tele-adapted a validated 90-minute yoga therapy module into a brief 30-minute format and evaluated its acceptability, feasibility, and preliminary clinical effects. Methods Using expert content validation (n = 10), we developed a 30-minute tele-yoga module comprising Sukshma Vyayama, Vibhagiya Pranayama (6:4:8:4 ratio), Chandra Anuloma Viloma (4:8 ratio), Nadishodhana Pranayama, Bhramari Pranayama, and Yoga Nidra. Twenty adults (18 to 55 years) diagnosed with GAD (GAD-7 score of 5 or higher), with or without comorbid neurotic disorder, on stable pharmacotherapy or drug-naive, received one in-person orientation followed by thrice-weekly live tele-yoga sessions and weekly yoga philosophy discussions over 8 weeks. Primary outcomes included feasibility metrics: Acceptability of Intervention Measure (AIM), Feasibility of Intervention Measure (FIM), Client Satisfaction Questionnaire (CSQ), attendance, dropout rate, and Yoga Performance Assessment (YPA). Secondary outcomes were GAD-7 and Pittsburgh Sleep Quality Index (PSQI) at baseline, 4 weeks, and 8 weeks. The Friedman test was used for repeated-measures analysis on completers (n = 17). Results Seventeen of 20 participants (85%) completed the intervention with over 80% attendance. Three withdrew for non-intervention reasons. All feasibility criteria were met: AIM 4.52 +/− 0.21, FIM 4.45 +/− 0.18, CSQ 30.05 +/− 1.14, YPA 30.11 +/− 1.36. GAD-7 scores decreased significantly from a median of 13.0 (IQR 11.0 to 15.0) at baseline to 7.0 (IQR 6.0 to 8.0) at 8 weeks (chi-square = 33.52, p < 0.001). PSQI improved from 12.0 (IQR 11.0 to 15.0) to 7.0 (IQR 4.0 to 7.0) (chi-square = 31.39, p < 0.001). No adverse events occurred. Conclusions This brief tele-adapted yoga module is feasible, acceptable, and shows promising preliminary effects on anxiety and sleep quality in GAD. Randomized controlled trials are warranted.
- Open Access
- 30 September 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 125
Measuring the four paths: Development and psychometric properties of the Paths of Yoga Self Evaluation (POYSE)
- 30 September 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 125
Open AccessMeasuring the four paths: Development and psychometric properties of the Paths of Yoga Self Evaluation (POYSE)
- Open Access
- 4 September 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 577
Effect of Add-on Integrated Yoga and Ayurveda Management on Clinical and Neurobiological Parameters in Multiple Sclerosis: A Randomized Controlled Trial Protocol
Background Multiple sclerosis (MS) is a progressive autoimmune neurodegenerative disorder characterized by inflammation, demyelination, and axonal damage. Current disease-modifying therapies demonstrate limited efficacy with substantial adverse effects. Ayurveda and yoga have demonstrated disease-modifying potential through anti-inflammatory, immunomodulatory, and neuroprotective mechanisms. Objective This study aims to evaluate the efficacy of a three-month Integrated Yoga and Ayurveda Management (IYAM) program as an adjunct to standard care in MS patients. Primary outcomes include clinical disability (EDSS), functional capacity (MSFC), quality of life (MSQOL-54), cognition (AVLT), and psychological parameters (HARS/HDRS). Secondary outcomes encompass neuroimaging (brain volume, connectivity), immune biomarkers (Th1/Th2/Th17/Treg cells, cytokines, telomere length), autonomic function (HRV), and gut microbiome composition. Methods In this assessor-blind randomized controlled superiority trial, 60 MS patients (McDonald criteria 2017, disease duration <2 years) will be recruited from tertiary care settings after informed consent. Participants will be randomly allocated (1:1) to IYAM (Ayurvedic Rasayanas: Lashuna 16 days, Bala 36 days, Shatavari 36 days and 2 days alotted for sadhyovirechana, plus yoga therapy) or standard care. A computer-generated randomization sequence was created using the REDCap randomization module. Group assignments were concealed until participant enrollment, ensuring allocation concealment, with blinded assessors. Assessments at baseline, 45 days and three months include clinical scales, neuropsychological testing, 3 T MRI, immunophenotyping, and microbiome analysis. Intent-to-treat analysis with mixed repeated measures ANOVA. Expected Outcomes Significant improvements in disability, cognition, and quality of life are anticipated in IYAM group, mediated through neuroinflammatory modulation, enhanced neuroprotection, and favorable gut microbiome alterations. Trial Registration Clinical Trials Registry-India (CTRI/2024/12/078605); date of registration: 26 December 2024; dates of clinical trial: January 2025 to December 2027. Protocol Version Version 1.0, October 2025.
- 4 September 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 577
Open AccessEffect of Add-on Integrated Yoga and Ayurveda Management on Clinical and Neurobiological Parameters in Multiple Sclerosis: A Randomized Controlled Trial Protocol
Background Multiple sclerosis (MS) is a progressive autoimmune neurodegenerative disorder characterized by inflammation, demyelination, and axonal damage. Current disease-modifying therapies demonstrate limited efficacy with substantial adverse effects. Ayurveda and yoga have demonstrated disease-modifying potential through anti-inflammatory, immunomodulatory, and neuroprotective mechanisms. Objective This study aims to evaluate the efficacy of a three-month Integrated Yoga and Ayurveda Management (IYAM) program as an adjunct to standard care in MS patients. Primary outcomes include clinical disability (EDSS), functional capacity (MSFC), quality of life (MSQOL-54), cognition (AVLT), and psychological parameters (HARS/HDRS). Secondary outcomes encompass neuroimaging (brain volume, connectivity), immune biomarkers (Th1/Th2/Th17/Treg cells, cytokines, telomere length), autonomic function (HRV), and gut microbiome composition. Methods In this assessor-blind randomized controlled superiority trial, 60 MS patients (McDonald criteria 2017, disease duration <2 years) will be recruited from tertiary care settings after informed consent. Participants will be randomly allocated (1:1) to IYAM (Ayurvedic Rasayanas: Lashuna 16 days, Bala 36 days, Shatavari 36 days and 2 days alotted for sadhyovirechana, plus yoga therapy) or standard care. A computer-generated randomization sequence was created using the REDCap randomization module. Group assignments were concealed until participant enrollment, ensuring allocation concealment, with blinded assessors. Assessments at baseline, 45 days and three months include clinical scales, neuropsychological testing, 3 T MRI, immunophenotyping, and microbiome analysis. Intent-to-treat analysis with mixed repeated measures ANOVA. Expected Outcomes Significant improvements in disability, cognition, and quality of life are anticipated in IYAM group, mediated through neuroinflammatory modulation, enhanced neuroprotection, and favorable gut microbiome alterations. Trial Registration Clinical Trials Registry-India (CTRI/2024/12/078605); date of registration: 26 December 2024; dates of clinical trial: January 2025 to December 2027. Protocol Version Version 1.0, October 2025.
- Open Access
- 11 August 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Efficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide, and 7-day point-prevalence abstinence (7PPA). In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on an as-neededs basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8 th week. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- 11 August 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Open AccessEfficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide, and 7-day point-prevalence abstinence (7PPA). In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on an as-neededs basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8 th week. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- Open Access
- 7 July 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 426
Transformational Versus Transactional Mindsets in Long-Term Tele-Yoga Practice: A Five-Year Prospective Cohort Follow-Up Study with Mixed-Methods Analysis
Background In 2020, we established a community-based tele-yoga cohort during COVID-19 and demonstrated short-term stress reduction benefits. Long-term outcomes and psychological mechanisms underlying differential adherence patterns remained unexplored. Objective To evaluate psychological outcomes at five-year follow-up and explore mechanisms differentiating regular from irregular practitioners in a prospectively followed tele-yoga cohort. Methods This mixed-methods prospective cohort follow-up study assessed participants from our 2020 tele-yoga program. Baseline assessments (PSS, SWLS, WHOQOL-BREF, Gunas) were collected at enrolment. Attendance was tracked continuously via session logs. At the five-year follow-up, we re-administered quantitative measures and conducted semi-structured interviews (30–45 minutes). Participants were classified as Regular (RTY; n = 20, >70% attendance) or Irregular (ITY; n = 20, <30% attendance) practitioners based on objective attendance records. Within-group changes were analyzed using paired tests; qualitative data using Braun and Clarke’s thematic analysis. Results RTY participants showed significant improvements from baseline in PSS (17.31 to 11.70, p = 0.01), SWLS (24.20 to 28.45, p = 0.004), and quality of life domains (Physical, Psychological, and Environmental; all p < 0.01). RTY showed significantly lower Rajas (p = 0.041) and Tamas (p = 0.01) than ITY. Within the RTY group, sessions attended correlated with improvement in PSS (r = 0.49, p < 0.05) and SWLS (r = 0.55, p < 0.05), indicating a dose-response relationship. ITY participants showed no improvements. Qualitative analysis identified four themes: intrapersonal transformation, interpersonal reorientation, facilitators of sustained engagement, and barriers to continuity. RTY participants demonstrated a “transformational mindset” characterized by mindful emotional awareness and intrinsic motivation, while ITY participants exhibited a “transactional mindset” emphasizing emotional control and instrumental yoga use. Conclusion This five-year prospective follow-up demonstrates sustained tele-yoga practice is associated with continued psychological benefits and transformational mindset development, while irregular practice shows stagnation or decline. The transformational-transactional framework provides insights for promoting long-term adherence to mind-body practices.
- 7 July 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 426
Open AccessTransformational Versus Transactional Mindsets in Long-Term Tele-Yoga Practice: A Five-Year Prospective Cohort Follow-Up Study with Mixed-Methods Analysis
Background In 2020, we established a community-based tele-yoga cohort during COVID-19 and demonstrated short-term stress reduction benefits. Long-term outcomes and psychological mechanisms underlying differential adherence patterns remained unexplored. Objective To evaluate psychological outcomes at five-year follow-up and explore mechanisms differentiating regular from irregular practitioners in a prospectively followed tele-yoga cohort. Methods This mixed-methods prospective cohort follow-up study assessed participants from our 2020 tele-yoga program. Baseline assessments (PSS, SWLS, WHOQOL-BREF, Gunas) were collected at enrolment. Attendance was tracked continuously via session logs. At the five-year follow-up, we re-administered quantitative measures and conducted semi-structured interviews (30–45 minutes). Participants were classified as Regular (RTY; n = 20, >70% attendance) or Irregular (ITY; n = 20, <30% attendance) practitioners based on objective attendance records. Within-group changes were analyzed using paired tests; qualitative data using Braun and Clarke’s thematic analysis. Results RTY participants showed significant improvements from baseline in PSS (17.31 to 11.70, p = 0.01), SWLS (24.20 to 28.45, p = 0.004), and quality of life domains (Physical, Psychological, and Environmental; all p < 0.01). RTY showed significantly lower Rajas (p = 0.041) and Tamas (p = 0.01) than ITY. Within the RTY group, sessions attended correlated with improvement in PSS (r = 0.49, p < 0.05) and SWLS (r = 0.55, p < 0.05), indicating a dose-response relationship. ITY participants showed no improvements. Qualitative analysis identified four themes: intrapersonal transformation, interpersonal reorientation, facilitators of sustained engagement, and barriers to continuity. RTY participants demonstrated a “transformational mindset” characterized by mindful emotional awareness and intrinsic motivation, while ITY participants exhibited a “transactional mindset” emphasizing emotional control and instrumental yoga use. Conclusion This five-year prospective follow-up demonstrates sustained tele-yoga practice is associated with continued psychological benefits and transformational mindset development, while irregular practice shows stagnation or decline. The transformational-transactional framework provides insights for promoting long-term adherence to mind-body practices.
- 2 July 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 122, 105083
Beyond physical practice: Validation and feasibility of a yoga-based counselling program (YBCP) for common mental disorders
- 2 July 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 122, 105083
Beyond physical practice: Validation and feasibility of a yoga-based counselling program (YBCP) for common mental disorders
- Open Access
- 5 June 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Efficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide. In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on sos basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8thweek. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- 5 June 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 9, 693
Open AccessEfficacy of yoga-breath linked intervention to stop smoking (Y-BLISS) in reducing the number of cigarettes smoked per day among smokers attempting to reduce or quit: Study protocol for a randomized controlled trial
Background The proposed research aims to test the effects of a two-month yoga-breath linked intervention to stop smoking (Y-BLISS) as an add-on to standard treatment in tobacco use disorder (TUD; in the form of cigarette smoking) by conducting a randomized controlled study with the following primary outcome variable: number of cigarettes smoked per day. Secondary outcome variables are motivation to stop smoking, craving, dependence severity, lung capacity, and exhaled carbon-monoxide. In this single-blinded, randomized, controlled, parallel-group superiority trial with 1:1 allocation ratio, 100 patients with TUD availing the outpatient/inpatient clinical services at a tertiary mental healthcare hospital in India will be enrolled after giving informed consent. Consecutive consenting patients will be randomly allotted to one of the two groups – yoga arm (Y-bliss arm), or desktop exercise arm (D-exercise arm). Allocation concealment will be followed, the clinicians, outcome assessors and data analysts will remain blind to subject-group allocation. A validated and standardized 12-minute yoga program (Y-BLISS) for TUD will be used as an intervention. The control group will receive an equivalent 12-minute desktop exercise module. Participants in respective arms will receive 40 online supervised sessions over 8 weeks, 5 sessions per week in the mornings as they will be asked to practice the same on sos basis whenever they feel cravings for cigarette smoking. Assessments will be done at baseline, 4th week and 8thweek. Data from all randomized subjects will be analyzed using intent-to-treat analysis and mixed model multivariate analysis. Dissemination Findings will be disseminated through peer-reviewed publications, conference presentations, and social media. Trial registration number The trial has been registered under Clinical Trials Registry India (CTRI) with the registration number: CTRI/2022/12/048117, date of registration: 14 th December 2022.
- 23 April 2026
- Published by Elsevier in Advances in Integrative Medicine
- Vol. 13 (2)
Development and feasibility of a clinic-based integrated yoga therapy module for patients with multiple sclerosis
- 23 April 2026
- Published by Elsevier in Advances in Integrative Medicine
- Vol. 13 (2)
Development and feasibility of a clinic-based integrated yoga therapy module for patients with multiple sclerosis
- Open Access
- 8 April 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 208
Development, Validation and Feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for Children with ADHD: A Cross-Sectional Pilot Study
Background Motor dysregulation occurs in 30–50% of children with Attention-Deficit/Hyperactivity Disorder (ADHD), reflecting impairments in neuromuscular control linked to fronto-striato-cerebellar circuitry. Conventional motor batteries may not adequately capture ADHD-specific regulatory deficits. This study aimed to develop, validate, and evaluate the feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for children with ADHD. Methods A cross-sectional pilot study was conducted at a tertiary psychiatric centre in India. Seven motor domains implicated in ADHD were identified through a literature review and mapped to yoga-based tasks by subject experts. Content validity was assessed using Lawshe’s Content Validity Ratio (CVR). Using purposive sampling, 24 children aged 8–15 years (12 ADHD, 12 typically developing controls) underwent Y-MAT assessment. ADHD symptom severity and adaptive functioning were evaluated using the ADHD Rating Scale (ADHD-RS) and Vineland Social Maturity Scale. Video recordings were independently scored by two blinded raters. An AI prototype employing pose estimation (Google MediaPipe and YOLOv8) was piloted on selected domains. Results Five yoga-based tasks achieved CVR = 1.00 and constituted the final Y-MAT. Feasibility metrics demonstrated high acceptability, demand, implementation fidelity, and practicality. Children with ADHD scored significantly lower than controls (human rating: 10.8 ± 7.1 vs 23.8 ± 4.0, p < 0.001; AI scoring: 12.5 ± 5.9 vs 19.1 ± 2.2, p = 0.002). Inter-rater reliability ranged from Kendall’s W = 0.23 to 0.55. Y-MAT total scores showed significant negative correlations with ADHD symptom severity. ROC analysis demonstrated excellent discriminatory validity (AUC = 0.910 human scoring; AUC = 0.896 AI scoring). Conclusions Y-MAT demonstrates preliminary validity and strong feasibility as a culturally grounded motor regulation assessment for children with ADHD. The AI prototype provides proof of concept for objective, scalable screening. Larger multi-centre studies are needed to establish psychometric robustness and normative thresholds.
- 8 April 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 208
Open AccessDevelopment, Validation and Feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for Children with ADHD: A Cross-Sectional Pilot Study
Background Motor dysregulation occurs in 30–50% of children with Attention-Deficit/Hyperactivity Disorder (ADHD), reflecting impairments in neuromuscular control linked to fronto-striato-cerebellar circuitry. Conventional motor batteries may not adequately capture ADHD-specific regulatory deficits. This study aimed to develop, validate, and evaluate the feasibility of a Yoga-Based Motor Assessment Tool (Y-MAT) for children with ADHD. Methods A cross-sectional pilot study was conducted at a tertiary psychiatric centre in India. Seven motor domains implicated in ADHD were identified through a literature review and mapped to yoga-based tasks by subject experts. Content validity was assessed using Lawshe’s Content Validity Ratio (CVR). Using purposive sampling, 24 children aged 8–15 years (12 ADHD, 12 typically developing controls) underwent Y-MAT assessment. ADHD symptom severity and adaptive functioning were evaluated using the ADHD Rating Scale (ADHD-RS) and Vineland Social Maturity Scale. Video recordings were independently scored by two blinded raters. An AI prototype employing pose estimation (Google MediaPipe and YOLOv8) was piloted on selected domains. Results Five yoga-based tasks achieved CVR = 1.00 and constituted the final Y-MAT. Feasibility metrics demonstrated high acceptability, demand, implementation fidelity, and practicality. Children with ADHD scored significantly lower than controls (human rating: 10.8 ± 7.1 vs 23.8 ± 4.0, p < 0.001; AI scoring: 12.5 ± 5.9 vs 19.1 ± 2.2, p = 0.002). Inter-rater reliability ranged from Kendall’s W = 0.23 to 0.55. Y-MAT total scores showed significant negative correlations with ADHD symptom severity. ROC analysis demonstrated excellent discriminatory validity (AUC = 0.910 human scoring; AUC = 0.896 AI scoring). Conclusions Y-MAT demonstrates preliminary validity and strong feasibility as a culturally grounded motor regulation assessment for children with ADHD. The AI prototype provides proof of concept for objective, scalable screening. Larger multi-centre studies are needed to establish psychometric robustness and normative thresholds.